{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:59:01Z","timestamp":1781225941511,"version":"3.54.1"},"reference-count":125,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["BT\/RLF\/Re-entry\/38\/2017"],"award-info":[{"award-number":["BT\/RLF\/Re-entry\/38\/2017"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Funct Integr Genomics"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s10142-026-01921-0","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:13:50Z","timestamp":1781223230000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["An integrative mutational and network analysis of pancreatic cancer reveals key genes, and signalling pathways"],"prefix":"10.1007","volume":"26","author":[{"given":"Gowrang Kasaba","family":"Manjunath","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lasya Priya","family":"Kanchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tikam Chand","family":"Dakal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhijit","family":"Beura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,12]]},"reference":[{"key":"1921_CR2","doi-asserted-by":"publisher","first-page":"3014","DOI":"10.1002\/ijc.32040","volume":"144","author":"M Amit","year":"2019","unstructured":"Amit M, Na\u2019ara S, Fridman E, Vladovski E, Wasserman T, Milman N, Gil Z (2019) RET, a targetable driver of pancreatic adenocarcinoma. Int J Cancer 144:3014\u20133022. https:\/\/doi.org\/10.1002\/ijc.32040","journal-title":"Int J Cancer"},{"key":"1921_CR3","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.molmed.2013.03.003","volume":"19","author":"JL Avila","year":"2013","unstructured":"Avila JL, Kissil JL (2013) Notch signaling in pancreatic cancer: oncogene or tumor suppressor? Trends Mol Med 19:320\u2013327. https:\/\/doi.org\/10.1016\/j.molmed.2013.03.003","journal-title":"Trends Mol Med"},{"key":"1921_CR4","doi-asserted-by":"publisher","first-page":"78","DOI":"10.21873\/cdp.10079","volume":"2","author":"JH Baek","year":"2022","unstructured":"Baek JH, Kim J, Baek DW, Chang E, Kim HJ, Park SY, Park JS, Choi GS, Kang BW, Kim JG (2022) Clinical implication of KRAS mutation variants in patients with resected colon cancer. Cancer diagnosis prognosis 2:78\u201383. https:\/\/doi.org\/10.21873\/cdp.10079","journal-title":"Cancer diagnosis prognosis"},{"key":"1921_CR5","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nature16965","volume":"531","author":"P Bailey","year":"2016","unstructured":"Bailey P, Chang DK, Nones K, Johns AL, Patch AM, Gingras MC, Miller DK, Christ AN, Bruxner TJ, Quinn MC, Nourse C, Murtaugh LC, Harliwong I, Idrisoglu S, Manning S, Nourbakhsh E, Wani S, Fink L, Holmes O, Chin V, Anderson MJ, Kazakoff S, Leonard C, Newell F, Waddell N, Wood S, Xu Q, Wilson PJ, Cloonan N, Kassahn KS, Taylor D, Quek K, Robertson A, Pantano L, Mincarelli L, Sanchez LN, Evers L, Wu J, Pinese M, Cowley MJ, Jones MD, Colvin EK, Nagrial AM, Humphrey ES, Chantrill LA, Mawson A, Humphris J, Chou A, Pajic M, Scarlett CJ, Pinho AV, Giry-Laterriere M, Rooman I, Samra JS, Kench JG, Lovell JA, Merrett ND, Toon CW, Epari K, Nguyen NQ, Barbour A, Zeps N, Moran-Jones K, Jamieson NB, Graham JS, Duthie F, Oien K, Hair J, Grutzmann R, Maitra A, Iacobuzio-Donahue CA, Wolfgang CL, Morgan RA, Lawlor RT, Corbo V, Bassi C, Rusev B, Capelli P, Salvia R, Tortora G, Mukhopadhyay D, Petersen GM, Munzy DM, Fisher WE, Karim SA, Eshleman JR, Hruban RH, Pilarsky C, Morton JP, Sansom OJ, Scarpa A, Musgrove EA, Bailey UM, Hofmann O, Sutherland RL, Wheeler DA, Gill AJ, Gibbs RA, Pearson JV, Waddell N, Biankin AV, Grimmond SM (2016) Genomic analyses identify molecular subtypes of pancreatic cancer. Nature 531:47\u201352. https:\/\/doi.org\/10.1038\/nature16965","journal-title":"Nature"},{"key":"1921_CR6","doi-asserted-by":"publisher","unstructured":"Bazzichetto C, Conciatori F, Pallocca M, Falcone I, Fanciulli M, Cognetti F, Milella M, Ciuffreda L (2019) PTEN as a prognostic\/predictive biomarker in cancer: An unfulfilled promise? Cancers (Basel) 11. https:\/\/doi.org\/10.3390\/cancers11040435","DOI":"10.3390\/cancers11040435"},{"key":"1921_CR7","doi-asserted-by":"publisher","first-page":"11182","DOI":"10.3748\/wjg.v20.i32.11182","volume":"20","author":"AE Becker","year":"2014","unstructured":"Becker AE, Hernandez YG, Frucht H, Lucas AL (2014) Pancreatic ductal adenocarcinoma: risk factors, screening, and early detection. World J Gastroenterol 20:11182\u201311198. https:\/\/doi.org\/10.3748\/wjg.v20.i32.11182","journal-title":"World J Gastroenterol"},{"key":"1921_CR8","doi-asserted-by":"publisher","first-page":"a003129","DOI":"10.1101\/cshperspect.a003129","volume":"1","author":"G Berx","year":"2009","unstructured":"Berx G, van Roy F (2009) Involvement of members of the cadherin superfamily in cancer. Cold Spring Harb Perspect Biol 1:a003129. https:\/\/doi.org\/10.1101\/cshperspect.a003129","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"1921_CR9","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1093\/annonc\/mdr541","volume":"23","author":"C Bosetti","year":"2012","unstructured":"Bosetti C, Lucenteforte E, Silverman DT, Petersen G, Bracci PM, Ji BT, Negri E, Li D, Risch HA, Olson SH, Gallinger S, Miller AB, Bueno-de-Mesquita HB, Talamini R, Polesel J, Ghadirian P, Baghurst PA, Zatonski W, Fontham E, Bamlet WR, Holly EA, Bertuccio P, Gao YT, Hassan M, Yu H, Kurtz RC, Cotterchio M, Su J, Maisonneuve P, Duell EJ, Boffetta P, La Vecchia C (2012) Cigarette smoking and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (Panc4). Ann Oncol 23:1880\u20131888. https:\/\/doi.org\/10.1093\/annonc\/mdr541","journal-title":"Ann Oncol"},{"key":"1921_CR10","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/s41575-019-0245-4","volume":"17","author":"L Buscail","year":"2020","unstructured":"Buscail L, Bournet B, Cordelier P (2020) Role of oncogenic KRAS in the diagnosis, prognosis and treatment of pancreatic cancer. Nat Reviews Gastroenterol Hepatol 17:153\u2013168. https:\/\/doi.org\/10.1038\/s41575-019-0245-4","journal-title":"Nat Reviews Gastroenterol Hepatol"},{"key":"1921_CR11","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1158\/1078-0432.CCR-17-2262","volume":"24","author":"AJ Camblin","year":"2018","unstructured":"Camblin AJ, Pace EA, Adams S, Curley MD, Rimkunas V, Nie L, Tan G, Bloom T, Iadevaia S, Baum J, Minx C, Czibere A, Louis CU, Drummond DC, Nielsen UB, Schoeberl B, Pipas JM, Straubinger RM, Askoxylakis V, Lugovskoy AA (2018) Dual inhibition of IGF-1R and ErbB3 enhances the activity of gemcitabine and nab-paclitaxel in preclinical models of pancreatic cancer. Clin Cancer Res 24:2873\u20132885. https:\/\/doi.org\/10.1158\/1078-0432.CCR-17-2262","journal-title":"Clin Cancer Res"},{"key":"1921_CR12","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1038\/ng.2765","volume":"45","author":"S Cappello","year":"2013","unstructured":"Cappello S, Gray MJ, Badouel C, Lange S, Einsiedler M, Srour M, Chitayat D, Hamdan FF, Jenkins ZA, Morgan T, Preitner N, Uster T, Thomas J, Shannon P, Morrison V, Di Donato N, Van Maldergem L, Neuhann T, Newbury-Ecob R, Swinkells M, Terhal P, Wilson LC, Zwijnenburg PJ, Sutherland-Smith AJ, Black MA, Markie D, Michaud JL, Simpson MA, Mansour S, McNeill H, Gotz M, Robertson SP (2013) Mutations in genes encoding the cadherin receptor-ligand pair DCHS1 and FAT4 disrupt cerebral cortical development. Nat Genet 45:1300\u20131308. https:\/\/doi.org\/10.1038\/ng.2765","journal-title":"Nat Genet"},{"key":"1921_CR13","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.gie.2020.06.069","volume":"93","author":"S Carrara","year":"2021","unstructured":"Carrara S, Solda G, Di Leo M, Rahal D, Peano C, Giunta M, Lamonaca L, Auriemma F, Anderloni A, Fugazza A, Maselli R, Malesci A, Laghi L, Repici A (2021) Side-by-side comparison of next-generation sequencing, cytology, and histology in diagnosing locally advanced pancreatic adenocarcinoma. Gastrointest Endosc 93:597\u2013604e595. https:\/\/doi.org\/10.1016\/j.gie.2020.06.069","journal-title":"Gastrointest Endosc"},{"key":"1921_CR14","doi-asserted-by":"publisher","first-page":"4271","DOI":"10.1038\/s41388-020-1289-1","volume":"39","author":"DD Cave","year":"2020","unstructured":"Cave DD, Di Guida M, Costa V, Sevillano M, Ferrante L, Heeschen C, Corona M, Cucciardi A, Lonardo E (2020) TGF-beta1 secreted by pancreatic stellate cells promotes stemness and tumourigenicity in pancreatic cancer cells through L1CAM downregulation. Oncogene 39:4271\u20134285. https:\/\/doi.org\/10.1038\/s41388-020-1289-1","journal-title":"Oncogene"},{"key":"1921_CR15","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13053-021-00178-x","volume":"19","author":"SH Chan","year":"2021","unstructured":"Chan SH, Chiang J, Ngeow J (2021) CDKN2A germline alterations and the relevance of genotype-phenotype associations in cancer predisposition. Hered Cancer Clin Pract 19:21. https:\/\/doi.org\/10.1186\/s13053-021-00178-x","journal-title":"Hered Cancer Clin Pract"},{"key":"1921_CR16","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1002\/gcc.10207","volume":"37","author":"A Charest","year":"2003","unstructured":"Charest A, Lane K, McMahon K, Park J, Preisinger E, Conroy H, Housman D (2003) Fusion of FIG to the receptor tyrosine kinase ROS in a glioblastoma with an interstitial del(6)(q21q21). Genes Chromosomes Cancer 37:58\u201371. https:\/\/doi.org\/10.1002\/gcc.10207","journal-title":"Genes Chromosomes Cancer"},{"key":"1921_CR18","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/1471-2407-14-181","volume":"14","author":"Y-W Chen","year":"2014","unstructured":"Chen Y-W, Hsiao P-J, Weng C-C, Kuo K-K, Kuo T-L, Wu D-C, Hung W-C, Cheng K-H (2014) SMAD4 Loss triggers the phenotypic changes of pancreatic ductal adenocarcinoma cells. BMC Cancer 14:181. https:\/\/doi.org\/10.1186\/1471-2407-14-181","journal-title":"BMC Cancer"},{"key":"1921_CR17","doi-asserted-by":"publisher","first-page":"1415260","DOI":"10.3389\/fonc.2024.1415260","volume":"14","author":"X Chen","year":"2024","unstructured":"Chen X, Hu X, Liu T (2024) Development of liquid biopsy in detection and screening of pancreatic cancer. Front Oncol 14:1415260. https:\/\/doi.org\/10.3389\/fonc.2024.1415260","journal-title":"Front Oncol"},{"key":"1921_CR19","doi-asserted-by":"publisher","first-page":"175628482110148","DOI":"10.1177\/17562848211014818","volume":"14","author":"J Chi","year":"2021","unstructured":"Chi J, Chung SY, Parakrama R, Fayyaz F, Jose J, Saif MW (2021) The role of PARP inhibitors in BRCA mutated pancreatic cancer. Th Adv Gastroenterol 14:17562848211014818. https:\/\/doi.org\/10.1177\/17562848211014818","journal-title":"Th Adv Gastroenterol"},{"key":"1921_CR20","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.7150\/ijbs.16233","volume":"12","author":"WC Chou","year":"2016","unstructured":"Chou WC, Lin PH, Yeh YC, Shyr YM, Fang WL, Wang SE, Liu CY, Chang PM, Chen MH, Hung YP, Li CP, Chao Y, Chen MH (2016) Genes involved in angiogenesis and mTOR pathways are frequently mutated in Asian patients with pancreatic neuroendocrine tumors. Int J Biol Sci 12:1523\u20131532. https:\/\/doi.org\/10.7150\/ijbs.16233","journal-title":"Int J Biol Sci"},{"key":"1921_CR21","doi-asserted-by":"publisher","first-page":"e135","DOI":"10.1016\/S1470-2045(19)30795-8","volume":"21","author":"ES Christenson","year":"2020","unstructured":"Christenson ES, Jaffee E, Azad NS (2020) Current and emerging therapies for patients with advanced pancreatic ductal adenocarcinoma: a bright future. Lancet Oncol 21:e135\u2013e145. https:\/\/doi.org\/10.1016\/S1470-2045(19)30795-8","journal-title":"Lancet Oncol"},{"key":"1921_CR22","doi-asserted-by":"publisher","first-page":"3689","DOI":"10.1002\/cam4.3916","volume":"10","author":"Q Chu","year":"2021","unstructured":"Chu Q, Wang L, Zhang J, Wang W, Wang Y (2021) CDK5 positively regulates Notch1 signaling in pancreatic cancer cells by phosphorylation. Cancer Med 10:3689\u20133699. https:\/\/doi.org\/10.1002\/cam4.3916","journal-title":"Cancer Med"},{"key":"1921_CR23","doi-asserted-by":"publisher","first-page":"18614","DOI":"10.1038\/s41598-019-55156-0","volume":"9","author":"M Cives","year":"2019","unstructured":"Cives M, Partelli S, Palmirotta R, Lovero D, Mandriani B, Quaresmini D, Pelle E, Andreasi V, Castelli P, Strosberg J, Zamboni G, Falconi M, Silvestris F (2019) DAXX mutations as potential genomic markers of malignant evolution in small nonfunctioning pancreatic neuroendocrine tumors. Sci Rep 9:18614. https:\/\/doi.org\/10.1038\/s41598-019-55156-0","journal-title":"Sci Rep"},{"key":"1921_CR24","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s41575-019-0109-y","volume":"16","author":"EA Collisson","year":"2019","unstructured":"Collisson EA, Bailey P, Chang DK, Biankin AV (2019) Molecular subtypes of pancreatic cancer. Nat Rev Gastroenterol Hepatol 16:207\u2013220. https:\/\/doi.org\/10.1038\/s41575-019-0109-y","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1921_CR25","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.ccell.2018.12.010","volume":"35","author":"AA Connor","year":"2019","unstructured":"Connor AA, Denroche RE, Jang GH, Lemire M, Zhang A, Chan-Seng-Yue M, Wilson G, Grant RC, Merico D, Lungu I, Bartlett JMS, Chadwick D, Liang S-B, Eagles J, Mbabaali F, Miller JK, Krzyzanowski P, Armstrong H, Luo X, Jorgensen LGT, Romero JM, Bavi P, Fischer SE, Serra S, Hafezi-Bakhtiari S, Caglar D, Roehrl MHA, Cleary S, Hollingsworth MA, Petersen GM, Thayer S, Law CHL, Nanji S, Golan T, Smith AL, Borgida A, Dodd A, Hedley D, Wouters BG, O\u2019Kane GM, Wilson JM, Zogopoulos G, Notta F, Knox JJ, Gallinger S (2019) Integration of genomic and transcriptional features in pancreatic cancer reveals increased cell cycle progression in metastases. Cancer Cell 35:267\u2013282e267. https:\/\/doi.org\/10.1016\/j.ccell.2018.12.010","journal-title":"Cancer Cell"},{"key":"1921_CR26","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1158\/2159-8290.CD-17-0151","volume":"7","author":"APG Consortium","year":"2017","unstructured":"Consortium APG (2017) AACR Project GENIE: Powering Precision Medicine through an International Consortium. Cancer Discov 7:818\u2013831. https:\/\/doi.org\/10.1158\/2159-8290.CD-17-0151","journal-title":"Cancer Discov"},{"key":"1921_CR27","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1136\/gutjnl-2018-316822","volume":"68","author":"JR Conway","year":"2019","unstructured":"Conway JR, Herrmann D, Evans TJ, Morton JP, Timpson P (2019) Combating pancreatic cancer with PI3K pathway inhibitors in the era of personalised medicine. Gut 68:742\u2013758. https:\/\/doi.org\/10.1136\/gutjnl-2018-316822","journal-title":"Gut"},{"key":"1921_CR28","doi-asserted-by":"publisher","unstructured":"Dardare J, Witz A, Merlin JL, Gilson P, Harl\u00e9 A (2020) SMAD4 and the TGF\u03b2 pathway in patients with pancreatic ductal adenocarcinoma. Int J Mol Sci 21. https:\/\/doi.org\/10.3390\/ijms21103534","DOI":"10.3390\/ijms21103534"},{"key":"1921_CR29","doi-asserted-by":"publisher","first-page":"110401","DOI":"10.1016\/j.ygeno.2022.110401","volume":"114","author":"R Dhakar","year":"2022","unstructured":"Dhakar R, Dakal TC, Sharma A (2022) Genetic determinants of lung cancer: Understanding the oncogenic potential of somatic missense mutations. Genomics 114:110401. https:\/\/doi.org\/10.1016\/j.ygeno.2022.110401","journal-title":"Genomics"},{"key":"1921_CR30","first-page":"581","volume":"7","author":"D Dinu","year":"2014","unstructured":"Dinu D, Dobre M, Panaitescu E, B\u00eerl\u0103 R, Iosif C, Hoara P, Caragui A, Boeriu M, Constantinoiu S, Ardeleanu C (2014) Prognostic significance of KRAS gene mutations in colorectal cancer\u2013preliminary study. J Med Life 7:581\u2013587","journal-title":"J Med Life"},{"key":"1921_CR31","doi-asserted-by":"publisher","unstructured":"Dubrovsky G, Ross A, Jalali P, Lotze M (2024) Liquid biopsy in pancreatic ductal adenocarcinoma: A review of methods and applications. Int J Mol Sci 25. https:\/\/doi.org\/10.3390\/ijms252011013","DOI":"10.3390\/ijms252011013"},{"key":"1921_CR32","doi-asserted-by":"publisher","unstructured":"Duell EJ (2012) Epidemiology and potential mechanisms of tobacco smoking and heavy alcohol consumption in pancreatic cancer. 51:40\u201352. https:\/\/doi.org\/10.1002\/mc.20786","DOI":"10.1002\/mc.20786"},{"key":"1921_CR33","doi-asserted-by":"publisher","unstructured":"El-Gamal MI, Mewafi NH, Abdelmotteleb NE, Emara MA, Tarazi H, Sbenati RM, Madkour MM, Zaraei SO, Shahin AI, Anbar HS (2021) A review of HER4 (ErbB4) kinase, its impact on cancer, and Its Inhibitors. Molecules 26. https:\/\/doi.org\/10.3390\/molecules26237376","DOI":"10.3390\/molecules26237376"},{"key":"1921_CR34","doi-asserted-by":"publisher","unstructured":"Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, Cerami E, Sander C, Schultz N (2013a) Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. J Sci Signal 6:pl1\u2013pl1. https:\/\/doi.org\/10.1126\/scisignal.2004088","DOI":"10.1126\/scisignal.2004088"},{"key":"1921_CR36","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1053\/j.gastro.2013.02.037","volume":"144","author":"T Gao","year":"2013","unstructured":"Gao T, Zhou D, Yang C, Singh T, Penzo-Mendez A, Maddipati R, Tzatsos A, Bardeesy N, Avruch J, Stanger BZ (2013b) Hippo signaling regulates differentiation and maintenance in the exocrine pancreas. Gastroenterology 144:1543\u20131553 1553 e1541. https:\/\/doi.org\/10.1053\/j.gastro.2013.02.037","journal-title":"Gastroenterology"},{"key":"1921_CR35","first-page":"173","volume":"7","author":"J Gao","year":"2017","unstructured":"Gao J, Long B, Wang Z (2017) Role of Notch signaling pathway in pancreatic cancer. Am J Cancer Res 7:173\u2013186","journal-title":"Am J Cancer Res"},{"key":"1921_CR37","doi-asserted-by":"publisher","first-page":"5116","DOI":"10.1128\/MCB.01034-12","volume":"32","author":"NM George","year":"2012","unstructured":"George NM, Day CE, Boerner BP, Johnson RL, Sarvetnick NE (2012) Hippo signaling regulates pancreas development through inactivation of Yap. Mol Cell Biol 32:5116\u20135128. https:\/\/doi.org\/10.1128\/MCB.01034-12","journal-title":"Mol Cell Biol"},{"key":"1921_CR38","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1097\/mpa.0b013e31811f4526","volume":"35","author":"JJ Grzesiak","year":"2007","unstructured":"Grzesiak JJ, Ho JC, Moossa AR, Bouvet M (2007) The integrin-extracellular matrix axis in pancreatic cancer. Pancreas 35:293\u2013301. https:\/\/doi.org\/10.1097\/mpa.0b013e31811f4526","journal-title":"Pancreas"},{"key":"1921_CR123","doi-asserted-by":"publisher","unstructured":"Hannou SA, Wouters K, Paumelle R, Staels B. Functional genomics of the CDKN2A\/B locus in cardiovascular and metabolic disease: what have we learned from GWASs? Trends Endocrinol Metab. 2015;26(4):176-84.\u00a0 PMID: 25744911. https:\/\/doi.org\/10.1016\/j.tem.2015.01.008","DOI":"10.1016\/j.tem.2015.01.008"},{"key":"1921_CR39","doi-asserted-by":"publisher","first-page":"188556","DOI":"10.1016\/j.bbcan.2021.188556","volume":"1876","author":"LJ Hernandez Borrero","year":"2021","unstructured":"Hernandez Borrero LJ, El-Deiry WS (2021) Tumor suppressor p53: Biology, signaling pathways, and therapeutic targeting. Biochim Biophys Acta Rev Cancer 1876:188556. https:\/\/doi.org\/10.1016\/j.bbcan.2021.188556","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"1921_CR40","doi-asserted-by":"publisher","first-page":"3124","DOI":"10.1200\/jco.2014.59.7401","volume":"33","author":"S Holter","year":"2015","unstructured":"Holter S, Borgida A, Dodd A, Grant R, Semotiuk K, Hedley D, Dhani N, Narod S, Akbari M, Moore M, Gallinger S (2015) Germline BRCA mutations in a large clinic-based cohort of patients with pancreatic adenocarcinoma. J Clin Oncol 33:3124\u20133129. https:\/\/doi.org\/10.1200\/jco.2014.59.7401","journal-title":"J Clin Oncol"},{"key":"1921_CR41","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1001\/jamaoncol.2021.3701","volume":"7","author":"FC Hsu","year":"2021","unstructured":"Hsu FC, Roberts NJ, Childs E, Porter N, Rabe KG, Borgida A, Ukaegbu C, Goggins MG, Hruban RH, Zogopoulos G, Syngal S, Gallinger S, Petersen GM, Klein AP (2021) Risk of pancreatic cancer among individuals with pathogenic variants in the ATM gene. JAMA Oncol 7:1664\u20131668. https:\/\/doi.org\/10.1001\/jamaoncol.2021.3701","journal-title":"JAMA Oncol"},{"key":"1921_CR43","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1097\/PAI.0b013e3182655ab7","volume":"21","author":"H Hu","year":"2013","unstructured":"Hu H, Zhou L, Awadallah A, Xin W (2013) Significance of Notch1-signaling pathway in human pancreatic development and carcinogenesis. Appl Immunohistochem Mol Morphol 21:242\u2013247. https:\/\/doi.org\/10.1097\/PAI.0b013e3182655ab7","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"1921_CR45","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1158\/1535-7163.MCT-14-0501","volume":"14","author":"Y Hu","year":"2015","unstructured":"Hu Y, Su H, Li X, Guo G, Cheng L, Qin R, Qing G, Liu H (2015) The NOTCH ligand JAGGED2 promotes pancreatic cancer metastasis independent of NOTCH signaling activation. Mol Cancer Ther 14:289\u2013297. https:\/\/doi.org\/10.1158\/1535-7163.MCT-14-0501","journal-title":"Mol Cancer Ther"},{"key":"1921_CR42","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1001\/jama.2018.6228","volume":"319","author":"C Hu","year":"2018","unstructured":"Hu C, Hart SN, Polley EC, Gnanaolivu R, Shimelis H, Lee KY, Lilyquist J, Na J, Moore R, Antwi SO, Bamlet WR, Chaffee KG, DiCarlo J, Wu Z, Samara R, Kasi PM, McWilliams RR, Petersen GM, Couch FJ (2018) Association between inherited germline mutations in cancer predisposition genes and risk of pancreatic cancer. JAMA 319:2401\u20132409. https:\/\/doi.org\/10.1001\/jama.2018.6228","journal-title":"JAMA"},{"key":"1921_CR44","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1038\/s41401-020-00584-2","volume":"42","author":"H-f Hu","year":"2021","unstructured":"Hu H-f, Ye Z, Qin Y, Xu X-w, Yu X-j, Zhuo Q-f, Ji S-r (2021) Mutations in key driver genes of pancreatic cancer: molecularly targeted therapies and other clinical implications. Acta Pharmacol Sin 42:1725\u20131741. https:\/\/doi.org\/10.1038\/s41401-020-00584-2","journal-title":"Acta Pharmacol Sin"},{"key":"1921_CR46","doi-asserted-by":"publisher","first-page":"e10515","DOI":"10.15252\/emmm.201910515","volume":"11","author":"H Huang","year":"2019","unstructured":"Huang H, Zhang Y, Gallegos V, Sorrelle N, Zaid MM, Toombs J, Du W, Wright S, Hagopian M, Wang Z, Hosein AN, Sathe AA, Xing C, Koay EJ, Driscoll KE, Brekken RA (2019) Targeting TGFbetaR2-mutant tumors exposes vulnerabilities to stromal TGFbeta blockade in pancreatic cancer. EMBO Mol Med 11:e10515. https:\/\/doi.org\/10.15252\/emmm.201910515","journal-title":"EMBO Mol Med"},{"key":"1921_CR47","doi-asserted-by":"publisher","unstructured":"Huffman BM, Ellis H, Jordan AC, Freed-Pastor WA, Perez K, Rubinson DA, Sethi N, Singh H, Surana R, Wolpin BM, Aguirre AJ, Cleary JM (2022) Emerging role of targeted therapy in metastatic pancreatic adenocarcinoma. Cancers (Basel) 14. https:\/\/doi.org\/10.3390\/cancers14246223","DOI":"10.3390\/cancers14246223"},{"key":"1921_CR48","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.matbio.2022.03.010","volume":"110","author":"JD Humphries","year":"2022","unstructured":"Humphries JD, Zha J, Burns J, Askari JA, Below CR, Chastney MR, Jones MC, Mironov A, Knight D, O\u2019Reilly DA, Dunne MJ, Garrod DR, Jorgensen C, Humphries MJ (2022) Pancreatic ductal adenocarcinoma cells employ integrin alpha6beta4 to form hemidesmosomes and regulate cell proliferation. Matrix Biol 110:16\u201339. https:\/\/doi.org\/10.1016\/j.matbio.2022.03.010","journal-title":"Matrix Biol"},{"key":"1921_CR49","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s00423-007-0266-2","volume":"393","author":"S Iodice","year":"2008","unstructured":"Iodice S, Gandini S, Maisonneuve P, Lowenfels AB (2008) Tobacco and the risk of pancreatic cancer: a review and meta-analysis. Langenbecks Arch Surg 393:535\u2013545. https:\/\/doi.org\/10.1007\/s00423-007-0266-2","journal-title":"Langenbecks Arch Surg"},{"key":"1921_CR50","doi-asserted-by":"publisher","first-page":"112636","DOI":"10.18632\/oncotarget.22634","volume":"8","author":"N Ishii","year":"2017","unstructured":"Ishii N, Araki K, Yokobori T, Gantumur D, Yamanaka T, Altan B, Tsukagoshi M, Igarashi T, Watanabe A, Kubo N, Hosouchi Y, Kuwano H, Shirabe K (2017) Reduced FBXW7 expression in pancreatic cancer correlates with poor prognosis and chemotherapeutic resistance via accumulation of MCL1. Oncotarget 8:112636\u2013112646. https:\/\/doi.org\/10.18632\/oncotarget.22634","journal-title":"Oncotarget"},{"key":"1921_CR51","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1158\/1541-7786.MCR-18-1352","volume":"17","author":"S Jin","year":"2019","unstructured":"Jin S, Lee WC, Aust D, Pilarsky C, Cordes N (2019) beta8 Integrin Mediates Pancreatic Cancer Cell Radiochemoresistance. Mol Cancer Res 17:2126\u20132138. https:\/\/doi.org\/10.1158\/1541-7786.MCR-18-1352","journal-title":"Mol Cancer Res"},{"key":"1921_CR52","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.pharmthera.2019.04.010","volume":"200","author":"N Jurcak","year":"2019","unstructured":"Jurcak N, Zheng L (2019) Signaling in the microenvironment of pancreatic cancer: Transmitting along the nerve. Pharmacol Ther 200:126\u2013134. https:\/\/doi.org\/10.1016\/j.pharmthera.2019.04.010","journal-title":"Pharmacol Ther"},{"key":"1921_CR125","doi-asserted-by":"publisher","unstructured":"Jones S, Zhang X, Parsons DW, Lin JC, Leary RJ, Angenendt P, Mankoo P, Carter H, Kamiyama H, Jimeno A, Hong SM, Fu B, Lin MT, Calhoun ES, Kamiyama M, Walter K, Nikolskaya T, Nikolsky Y, Hartigan J, Smith DR, Hidalgo M, Leach SD, Klein AP, Jaffee EM, Goggins M, Maitra A, Iacobuzio-Donahue C, Eshleman JR, Kern SE, Hruban RH, Karchin R, Papadopoulos N, Parmigiani G, Vogelstein B, Velculescu VE, Kinzler KW. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science. 2008 Sep 26;321(5897):1801-6. PMID: 18772397 https:\/\/doi.org\/10.1126\/science.1164368","DOI":"10.1126\/science.1164368"},{"key":"1921_CR53","doi-asserted-by":"publisher","first-page":"3869","DOI":"10.1074\/jbc.C113.532267","volume":"289","author":"C Kahlert","year":"2014","unstructured":"Kahlert C, Melo SA, Protopopov A, Tang J, Seth S, Koch M, Zhang J, Weitz J, Chin L, Futreal A, Kalluri R (2014) Identification of double-stranded genomic DNA spanning all chromosomes with mutated KRAS and p53 DNA in the serum exosomes of patients with pancreatic cancer. J Biol Chem 289:3869\u20133875. https:\/\/doi.org\/10.1074\/jbc.C113.532267","journal-title":"J Biol Chem"},{"issue":"Pt 2","key":"1921_CR54","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1042\/bj3120471","volume":"312","author":"P Kaliman","year":"1995","unstructured":"Kaliman P, Vinals F, Testar X, Palacin M, Zorzano A (1995) Disruption of GLUT1 glucose carrier trafficking in L6E9 and Sol8 myoblasts by the phosphatidylinositol 3-kinase inhibitor wortmannin. Biochem J 312(Pt 2):471\u2013477. https:\/\/doi.org\/10.1042\/bj3120471","journal-title":"Biochem J"},{"key":"1921_CR55","doi-asserted-by":"publisher","first-page":"19331","DOI":"10.1016\/S0021-9258(17)32171-3","volume":"269","author":"T Komiyama","year":"1994","unstructured":"Komiyama T, Ray CA, Pickup DJ, Howard AD, Thornberry NA, Peterson EP, Salvesen G (1994) Inhibition of interleukin-1 beta converting enzyme by the cowpox virus serpin CrmA. An example of cross-class inhibition. J Biol Chem 269:19331\u201319337","journal-title":"J Biol Chem"},{"key":"1921_CR56","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nature05092","volume":"443","author":"J Krishnamurthy","year":"2006","unstructured":"Krishnamurthy J, Ramsey MR, Ligon KL, Torrice C, Koh A, Bonner-Weir S, Sharpless NE (2006) p16INK4a induces an age-dependent decline in islet regenerative potential. Nature 443:453\u2013457. https:\/\/doi.org\/10.1038\/nature05092","journal-title":"Nature"},{"key":"1921_CR57","doi-asserted-by":"publisher","unstructured":"Kubelt C, Hellmold D, Esser D, Ahmeti H, Synowitz M, Held-Feindt J (2023) Insights into gene regulation under temozolomide-promoted cellular dormancy and its connection to stemness in human glioblastoma. Cells 12. https:\/\/doi.org\/10.3390\/cells12111491","DOI":"10.3390\/cells12111491"},{"key":"1921_CR58","doi-asserted-by":"publisher","first-page":"W90","DOI":"10.1093\/nar\/gkw377","volume":"44","author":"MV Kuleshov","year":"2016","unstructured":"Kuleshov MV, Jones MR, Rouillard AD, Fernandez NF, Duan Q, Wang Z, Koplev S, Jenkins SL, Jagodnik KM, Lachmann A, McDermott MG, Monteiro CD, Gundersen GW, Ma\u2019ayan A (2016) Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res 44:W90\u201397. https:\/\/doi.org\/10.1093\/nar\/gkw377","journal-title":"Nucleic Acids Res"},{"key":"1921_CR59","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/bjc.2011.585","volume":"106","author":"SC Larsson","year":"2012","unstructured":"Larsson SC, Wolk A (2012) Red and processed meat consumption and risk of pancreatic cancer: meta-analysis of prospective studies. Br J Cancer 106:603\u2013607. https:\/\/doi.org\/10.1038\/bjc.2011.585","journal-title":"Br J Cancer"},{"key":"1921_CR60","first-page":"957","volume":"12","author":"W Li","year":"2019","unstructured":"Li W, Liu Y, Cai S, Yang C, Lin Z, Zhou L, Liu L, Cheng X, Zeng W (2019) Not all mutations of KRAS predict poor prognosis in patients with colorectal cancer. Int J Clin Exp Pathol 12:957\u2013967","journal-title":"Int J Clin Exp Pathol"},{"key":"1921_CR61","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1097\/00006676-199604000-00007","volume":"12","author":"M Lohr","year":"1996","unstructured":"Lohr M, Trautmann B, Gottler M, Peters S, Zauner I, Maier A, Kloppel G, Liebe S, Kreuser ED (1996) Expression and function of receptors for extracellular matrix proteins in human ductal adenocarcinomas of the pancreas. Pancreas 12:248\u2013259. https:\/\/doi.org\/10.1097\/00006676-199604000-00007","journal-title":"Pancreas"},{"key":"1921_CR62","doi-asserted-by":"publisher","first-page":"3913","DOI":"10.3892\/mmr.2016.5021","volume":"13","author":"J Long","year":"2016","unstructured":"Long J, Liu Z, Wu X, Xu Y, Ge C (2016) Gene expression profile analysis of pancreatic cancer based on microarray data. Mol Med Rep 13:3913\u20133919. https:\/\/doi.org\/10.3892\/mmr.2016.5021","journal-title":"Mol Med Rep"},{"key":"1921_CR63","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/sj.bjc.6605177","volume":"101","author":"F Loupakis","year":"2009","unstructured":"Loupakis F, Ruzzo A, Cremolini C, Vincenzi B, Salvatore L, Santini D, Masi G, Stasi I, Canestrari E, Rulli E, Floriani I, Bencardino K, Galluccio N, Catalano V, Tonini G, Magnani M, Fontanini G, Basolo F, Falcone A, Graziano F (2009) KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancer. Br J Cancer 101:715\u2013721. https:\/\/doi.org\/10.1038\/sj.bjc.6605177","journal-title":"Br J Cancer"},{"key":"1921_CR64","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.bpg.2005.10.001","volume":"20","author":"AB Lowenfels","year":"2006","unstructured":"Lowenfels AB, Maisonneuve P (2006) Epidemiology and risk factors for pancreatic cancer. Best Pract Res Clin Gastroenterol 20:197\u2013209. https:\/\/doi.org\/10.1016\/j.bpg.2005.10.001","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"1921_CR66","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1002\/path.4941","volume":"243","author":"C Luchini","year":"2017","unstructured":"Luchini C, Pea A, Lionheart G, Mafficini A, Nottegar A, Veronese N, Chianchiano P, Brosens LA, Noe M, Offerhaus GJA, Yonescu R, Ning Y, Malleo G, Riva G, Piccoli P, Cataldo I, Capelli P, Zamboni G, Scarpa A, Wood LD (2017) Pancreatic undifferentiated carcinoma with osteoclast-like giant cells is genetically similar to, but clinically distinct from, conventional ductal adenocarcinoma. J Pathol 243:148\u2013154. https:\/\/doi.org\/10.1002\/path.4941","journal-title":"J Pathol"},{"key":"1921_CR65","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1186\/s13046-020-01732-6","volume":"39","author":"C Luchini","year":"2020","unstructured":"Luchini C, Paolino G, Mattiolo P, Piredda ML, Cavaliere A, Gaule M, Melisi D, Salvia R, Malleo G, Shin JI, Cargnin S, Terrazzino S, Lawlor RT, Milella M, Scarpa A (2020) KRAS wild-type pancreatic ductal adenocarcinoma: molecular pathology and therapeutic opportunities. J Exp Clin Cancer Res 39:227. https:\/\/doi.org\/10.1186\/s13046-020-01732-6","journal-title":"J Exp Clin Cancer Res"},{"key":"1921_CR67","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1053\/j.seminoncol.2021.02.003","volume":"48","author":"J Luo","year":"2021","unstructured":"Luo J (2021) KRAS mutation in pancreatic cancer. Semin Oncol 48:10\u201318. https:\/\/doi.org\/10.1053\/j.seminoncol.2021.02.003","journal-title":"Semin Oncol"},{"key":"1921_CR68","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/1476-4598-13-51","volume":"13","author":"X Lyu","year":"2014","unstructured":"Lyu X, Fang W, Cai L, Zheng H, Ye Y, Zhang L, Li J, Peng H, Cho WC, Wang E, Marincola FM, Yao K, Cai H, Li J, Li X (2014) TGFbetaR2 is a major target of miR-93 in nasopharyngeal carcinoma aggressiveness. Mol Cancer 13:51. https:\/\/doi.org\/10.1186\/1476-4598-13-51","journal-title":"Mol Cancer"},{"key":"1921_CR69","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1016\/j.febslet.2012.01.054","volume":"586","author":"SP Malkoski","year":"2012","unstructured":"Malkoski SP, Wang XJ (2012) Two sides of the story? Smad4 loss in pancreatic cancer versus head-and-neck cancer. FEBS Lett 586:1984\u20131992. https:\/\/doi.org\/10.1016\/j.febslet.2012.01.054","journal-title":"FEBS Lett"},{"key":"1921_CR70","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/s41568-020-0290-x","volume":"20","author":"F Martinez-Jimenez","year":"2020","unstructured":"Martinez-Jimenez F, Muinos F, Sentis I, Deu-Pons J, Reyes-Salazar I, Arnedo-Pac C, Mularoni L, Pich O, Bonet J, Kranas H, Gonzalez-Perez A, Lopez-Bigas N (2020) A compendium of mutational cancer driver genes. Nat Rev Cancer 20:555\u2013572. https:\/\/doi.org\/10.1038\/s41568-020-0290-x","journal-title":"Nat Rev Cancer"},{"key":"1921_CR71","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1111\/j.1477-2574.2012.00504.x","volume":"14","author":"H Matthaei","year":"2012","unstructured":"Matthaei H, Wu J, Dal Molin M, Debeljak M, Lingohr P, Katabi N, Klimstra DS, Adsay NV, Eshleman JR, Schulick RD, Kinzler KW, Vogelstein B, Hruban RH, Maitra A (2012) GNAS codon 201 mutations are uncommon in intraductal papillary neoplasms of the bile duct. HPB: official J Int Hepato Pancreato Biliary Association 14:677\u2013683. https:\/\/doi.org\/10.1111\/j.1477-2574.2012.00504.x","journal-title":"HPB: official J Int Hepato Pancreato Biliary Association"},{"key":"1921_CR72","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/mc.20827","volume":"51","author":"AL McCleary-Wheeler","year":"2012","unstructured":"McCleary-Wheeler AL, McWilliams R, Fernandez-Zapico ME (2012) Aberrant signaling pathways in pancreatic cancer: a two compartment view. Mol Carcinog 51:25\u201339. https:\/\/doi.org\/10.1002\/mc.20827","journal-title":"Mol Carcinog"},{"key":"1921_CR73","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1002\/ijc.24695","volume":"126","author":"ST Mees","year":"2010","unstructured":"Mees ST, Mardin WA, Wendel C, Baeumer N, Willscher E, Senninger N, Schleicher C, Colombo-Benkmann M, Haier J (2010) EP300\u2013a miRNA-regulated metastasis suppressor gene in ductal adenocarcinomas of the pancreas. Int J Cancer 126:114\u2013124. https:\/\/doi.org\/10.1002\/ijc.24695","journal-title":"Int J Cancer"},{"key":"1921_CR74","doi-asserted-by":"publisher","unstructured":"Mehra S, Deshpande N, Nagathihalli N (2021) Targeting PI3K pathway in pancreatic ductal adenocarcinoma: rationale and progress. Cancers (Basel) 13. https:\/\/doi.org\/10.3390\/cancers13174434","DOI":"10.3390\/cancers13174434"},{"key":"1921_CR75","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1016\/S0140-6736(20)30974-0","volume":"395","author":"JD Mizrahi","year":"2020","unstructured":"Mizrahi JD, Surana R, Valle JW, Shroff RT (2020) Pancreatic cancer. Lancet 395:2008\u20132020. https:\/\/doi.org\/10.1016\/S0140-6736(20)30974-0","journal-title":"Lancet"},{"key":"1921_CR76","doi-asserted-by":"publisher","unstructured":"Modica C, Tortarolo D, Comoglio PM, Basilico C, Vigna E (2018) MET\/HGF Co-targeting in pancreatic cancer: A tool to provide insight into the tumor\/stroma crosstalk. Int J Mol Sci 19. https:\/\/doi.org\/10.3390\/ijms19123920","DOI":"10.3390\/ijms19123920"},{"key":"1921_CR77","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/nature19823","volume":"538","author":"F Notta","year":"2016","unstructured":"Notta F, Chan-Seng-Yue M, Lemire M, Li Y, Wilson GW, Connor AA, Denroche RE, Liang SB, Brown AM, Kim JC, Wang T, Simpson JT, Beck T, Borgida A, Buchner N, Chadwick D, Hafezi-Bakhtiari S, Dick JE, Heisler L, Hollingsworth MA, Ibrahimov E, Jang GH, Johns J, Jorgensen LG, Law C, Ludkovski O, Lungu I, Ng K, Pasternack D, Petersen GM, Shlush LI, Timms L, Tsao MS, Wilson JM, Yung CK, Zogopoulos G, Bartlett JM, Alexandrov LB, Real FX, Cleary SP, Roehrl MH, McPherson JD, Stein LD, Hudson TJ, Campbell PJ, Gallinger S (2016) A renewed model of pancreatic cancer evolution based on genomic rearrangement patterns. Nature 538:378\u2013382. https:\/\/doi.org\/10.1038\/nature19823","journal-title":"Nature"},{"key":"1921_CR78","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1038\/35059131","volume":"409","author":"N Ohtani","year":"2001","unstructured":"Ohtani N, Zebedee Z, Huot TJ, Stinson JA, Sugimoto M, Ohashi Y, Sharrocks AD, Peters G, Hara E (2001) Opposing effects of Ets and Id proteins on p16INK4a expression during cellular senescence. Nature 409:1067\u20131070. https:\/\/doi.org\/10.1038\/35059131","journal-title":"Nature"},{"key":"1921_CR79","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s13014-019-1345-6","volume":"14","author":"M Orth","year":"2019","unstructured":"Orth M, Metzger P, Gerum S, Mayerle J, Schneider G, Belka C, Schnurr M, Lauber K (2019) Pancreatic ductal adenocarcinoma: biological hallmarks, current status, and future perspectives of combined modality treatment approaches. Radiat Oncol 14:141. https:\/\/doi.org\/10.1186\/s13014-019-1345-6","journal-title":"Radiat Oncol"},{"key":"1921_CR80","doi-asserted-by":"publisher","first-page":"e169","DOI":"10.1038\/oncsis.2015.28","volume":"4","author":"SN Payne","year":"2015","unstructured":"Payne SN, Maher ME, Tran NH, Van De Hey DR, Foley TM, Yueh AE, Leystra AA, Pasch CA, Jeffrey JJ, Clipson L, Matkowskyj KA, Deming DA (2015) PIK3CA mutations can initiate pancreatic tumorigenesis and are targetable with PI3K inhibitors. Oncogenesis 4:e169. https:\/\/doi.org\/10.1038\/oncsis.2015.28","journal-title":"Oncogenesis"},{"key":"1921_CR81","doi-asserted-by":"publisher","unstructured":"Pelosi E, Castelli G, Testa U (2017) Pancreatic cancer: Molecular characterization, clonal evolution and cancer stem cells. Biomedicines 5. https:\/\/doi.org\/10.3390\/biomedicines5040065","DOI":"10.3390\/biomedicines5040065"},{"key":"1921_CR82","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.7150\/jca.14922","volume":"7","author":"K Polireddy","year":"2016","unstructured":"Polireddy K, Chen Q (2016) Cancer of the pancreas: Molecular pathways and current advancement in treatment. J Cancer 7:1497\u20131514. https:\/\/doi.org\/10.7150\/jca.14922","journal-title":"J Cancer"},{"key":"1921_CR83","doi-asserted-by":"publisher","unstructured":"Posternak V, Cole MD (2016) Strategically targeting MYC in cancer. F1000Res 5. https:\/\/doi.org\/10.12688\/f1000research.7879.1","DOI":"10.12688\/f1000research.7879.1"},{"key":"1921_CR84","doi-asserted-by":"publisher","first-page":"e60870","DOI":"10.1371\/journal.pone.0060870","volume":"8","author":"PS Rachakonda","year":"2013","unstructured":"Rachakonda PS, Bauer AS, Xie H, Campa D, Rizzato C, Canzian F, Beghelli S, Greenhalf W, Costello E, Schanne M, Heller A, Scarpa A, Neoptolemos JP, Werner J, Buchler M, Hoheisel JD, Hemminki K, Giese N, Kumar R (2013) Somatic mutations in exocrine pancreatic tumors: association with patient survival. PLoS ONE 8:e60870. https:\/\/doi.org\/10.1371\/journal.pone.0060870","journal-title":"PLoS ONE"},{"key":"1921_CR85","doi-asserted-by":"publisher","unstructured":"Ram Makena M, Gatla H, Verlekar D, Sukhavasi S, M KP, K CP (2019) Wnt\/beta-catenin signaling: The culprit in pancreatic carcinogenesis and therapeutic resistance. Int J Mol Sci 20. https:\/\/doi.org\/10.3390\/ijms20174242","DOI":"10.3390\/ijms20174242"},{"key":"1921_CR86","doi-asserted-by":"publisher","first-page":"111623","DOI":"10.1016\/j.celrep.2022.111623","volume":"41","author":"G Ramakrishnan","year":"2022","unstructured":"Ramakrishnan G, Parajuli P, Singh P, Friend C, Hurwitz E, Prunier C, Razzaque MS, Xu K, Atfi A (2022) NF1 loss of function as an alternative initiating event in pancreatic ductal adenocarcinoma. Cell Rep 41:111623. https:\/\/doi.org\/10.1016\/j.celrep.2022.111623","journal-title":"Cell Rep"},{"key":"1921_CR1","doi-asserted-by":"publisher","unstructured":"Raphael, BJ et al. (2017) Integrated genomic characterization of pancreatic ductal adenocarcinoma. Cancer Cell 32:185\u2013203.e113. https:\/\/doi.org\/10.1016\/j.ccell.2017.07.007","DOI":"10.1016\/j.ccell.2017.07.007"},{"key":"1921_CR87","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.3390\/cancers7030860","volume":"7","author":"T Regad","year":"2015","unstructured":"Regad T (2015) Targeting RTK signaling pathways in cancer. Cancers (Basel) 7:1758\u20131784. https:\/\/doi.org\/10.3390\/cancers7030860","journal-title":"Cancers (Basel)"},{"issue":"Suppl 4","key":"1921_CR88","doi-asserted-by":"publisher","first-page":"iv44","DOI":"10.1093\/annonc\/mdi907","volume":"16","author":"A Russo","year":"2005","unstructured":"Russo A, Bazan V, Agnese V, Rodolico V, Gebbia N (2005) Prognostic and predictive factors in colorectal cancer: Kirsten Ras in CRC (RASCAL) and TP53CRC collaborative studies. Annals oncology: official J Eur Soc Med Oncol 16(Suppl 4):iv44\u201349. https:\/\/doi.org\/10.1093\/annonc\/mdi907","journal-title":"Annals oncology: official J Eur Soc Med Oncol"},{"key":"1921_CR89","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1097\/01.MP.0000075645.97329.86","volume":"16","author":"F Sahin","year":"2003","unstructured":"Sahin F, Maitra A, Argani P, Sato N, Maehara N, Montgomery E, Goggins M, Hruban RH, Su GH (2003) Loss of Stk11\/Lkb1 expression in pancreatic and biliary neoplasms. Mod Pathol 16:686\u2013691. https:\/\/doi.org\/10.1097\/01.MP.0000075645.97329.86","journal-title":"Mod Pathol"},{"key":"1921_CR90","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s13402-020-00499-4","volume":"43","author":"VFM Segers","year":"2020","unstructured":"Segers VFM, Dugaucquier L, Feyen E, Shakeri H, De Keulenaer GW (2020) The role of ErbB4 in cancer. Cell Oncol (Dordr) 43:335\u2013352. https:\/\/doi.org\/10.1007\/s13402-020-00499-4","journal-title":"Cell Oncol (Dordr)"},{"key":"1921_CR124","doi-asserted-by":"publisher","unstructured":"Sharpless NE, Sherr CJ. Forging a signature of in vivo senescence. Nat Rev Cancer. 2015 Jul;15(7):397-408. doi: 10.1038\/nrc3960.\u00a0 https:\/\/doi.org\/10.1038\/nrc3960","DOI":"10.1038\/nrc3960"},{"key":"1921_CR92","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13578-017-0168-0","volume":"7","author":"W Shen","year":"2017","unstructured":"Shen W, Tao GQ, Zhang Y, Cai B, Sun J, Tian ZQ (2017) TGF-beta in pancreatic cancer initiation and progression: two sides of the same coin. Cell Biosci 7:39. https:\/\/doi.org\/10.1186\/s13578-017-0168-0","journal-title":"Cell Biosci"},{"key":"1921_CR91","doi-asserted-by":"publisher","unstructured":"ShenG-Q, Aleassa EM, Walsh RM, Morris-Stiff G (2019) Next-generation sequencing in pancreatic cancer. Pancreas 48 (6):739\u2013748. https:\/\/doi.org\/10.1097\/mpa.0000000000001324","DOI":"10.1097\/mpa.0000000000001324"},{"key":"1921_CR93","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A (2023) Cancer statistics, 2023. Cancer J Clin 73:17\u201348. https:\/\/doi.org\/10.3322\/caac.21763","journal-title":"Cancer J Clin"},{"key":"1921_CR94","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/s41374-020-00490-5","volume":"101","author":"K Singh","year":"2021","unstructured":"Singh K, Pruski M, Bland R, Younes M, Guha S, Thosani N, Maitra A, Cash BD, McAllister F, Logsdon CD, Chang JT, Bailey-Lundberg JM (2021) ) <\u2009em>Kras mutation rate precisely orchestrates ductal derived pancreatic intraepithelial neoplasia and pancreatic cancer. Lab Invest 101:177\u2013192. https:\/\/doi.org\/10.1038\/s41374-020-00490-5","journal-title":"Lab Invest"},{"key":"1921_CR95","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12885-017-3957-2","volume":"18","author":"H Song","year":"2018","unstructured":"Song H, Zhang Y (2018) Regulation of pancreatic stellate cell activation by Notch3. BMC Cancer 18:36. https:\/\/doi.org\/10.1186\/s12885-017-3957-2","journal-title":"BMC Cancer"},{"key":"1921_CR96","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1159\/000084490","volume":"5","author":"J Standop","year":"2005","unstructured":"Standop J, Andrianifahanana M, Moniaux N, Schneider M, Ulrich A, Brand RE, Wisecarver JL, Bridge JA, Buchler MW, Adrian TE, Batra SK, Pour PM (2005) ErbB2 growth factor receptor, a marker for neuroendocrine cells? Pancreatology 5:44\u201358. https:\/\/doi.org\/10.1159\/000084490","journal-title":"Pancreatology"},{"key":"1921_CR97","doi-asserted-by":"publisher","first-page":"2827","DOI":"10.3390\/cimb46040177","volume":"46","author":"D Stefanoudakis","year":"2024","unstructured":"Stefanoudakis D, Frountzas M, Schizas D, Michalopoulos NV, Drakaki A, Toutouzas KG (2024) Significance of TP53, CDKN2A, SMAD4 and KRAS in Pancreatic Cancer. Curr Issues Mol Biol 46:2827\u20132844. https:\/\/doi.org\/10.3390\/cimb46040177","journal-title":"Curr Issues Mol Biol"},{"key":"1921_CR98","doi-asserted-by":"publisher","first-page":"799","DOI":"10.32604\/or.2024.045356","volume":"32","author":"S Stickler","year":"2024","unstructured":"Stickler S, Rath B, Hamilton G (2024) Targeting KRAS in pancreatic cancer. Oncol Res 32:799\u2013805. https:\/\/doi.org\/10.32604\/or.2024.045356","journal-title":"Oncol Res"},{"key":"1921_CR99","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1053\/j.gastro.2020.02.059","volume":"158","author":"P Storz","year":"2020","unstructured":"Storz P, Crawford HC (2020) Carcinogenesis of pancreatic ductal adenocarcinoma. Gastroenterology 158:2072\u20132081. https:\/\/doi.org\/10.1053\/j.gastro.2020.02.059","journal-title":"Gastroenterology"},{"key":"1921_CR100","doi-asserted-by":"publisher","unstructured":"Takahashi R, Ijichi H, Fujishiro M (2022) The role of neural signaling in the pancreatic cancer microenvironment. Cancers (Basel) 14. https:\/\/doi.org\/10.3390\/cancers14174269","DOI":"10.3390\/cancers14174269"},{"key":"1921_CR101","doi-asserted-by":"publisher","first-page":"8480","DOI":"10.3748\/wjg.v22.i38.8480","volume":"22","author":"E Takai","year":"2016","unstructured":"Takai E, Yachida S (2016) Circulating tumor DNA as a liquid biopsy target for detection of pancreatic cancer. World J Gastroenterol 22:8480\u20138488. https:\/\/doi.org\/10.3748\/wjg.v22.i38.8480","journal-title":"World J Gastroenterol"},{"key":"1921_CR102","doi-asserted-by":"publisher","first-page":"D941","DOI":"10.1093\/nar\/gky1015","volume":"47","author":"JG Tate","year":"2019","unstructured":"Tate JG, Bamford S, Jubb HC, Sondka Z, Beare DM, Bindal N, Boutselakis H, Cole CG, Creatore C, Dawson E, Fish P, Harsha B, Hathaway C, Jupe SC, Kok CY, Noble K, Ponting L, Ramshaw CC, Rye CE, Speedy HE, Stefancsik R, Thompson SL, Wang S, Ward S, Campbell PJ, Forbes SA (2019) COSMIC: the catalogue of somatic mutations in cancer. Nucleic Acids Res 47:D941\u2013D947. https:\/\/doi.org\/10.1093\/nar\/gky1015","journal-title":"Nucleic Acids Res"},{"key":"1921_CR103","doi-asserted-by":"publisher","first-page":"R67","DOI":"10.1530\/JME-12-0259","volume":"50","author":"M Trajkovic-Arsic","year":"2013","unstructured":"Trajkovic-Arsic M, Kalideris E, Siveke JT (2013) The role of insulin and IGF system in pancreatic cancer. J Mol Endocrinol 50:R67\u201374. https:\/\/doi.org\/10.1530\/JME-12-0259","journal-title":"J Mol Endocrinol"},{"key":"1921_CR104","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1159\/000108959","volume":"7","author":"MJ Truty","year":"2007","unstructured":"Truty MJ, Urrutia R (2007) Basics of TGF-beta and pancreatic cancer. Pancreatology 7:423\u2013435. https:\/\/doi.org\/10.1159\/000108959","journal-title":"Pancreatology"},{"key":"1921_CR105","doi-asserted-by":"publisher","first-page":"315","DOI":"10.14701\/ahbps.2021.25.3.315","volume":"25","author":"IA Voutsadakis","year":"2021","unstructured":"Voutsadakis IA (2021) Mutations of p53 associated with pancreatic cancer and therapeutic implications. Annals hepato-biliary-pancreatic Surg 25:315\u2013327. https:\/\/doi.org\/10.14701\/ahbps.2021.25.3.315","journal-title":"Annals hepato-biliary-pancreatic Surg"},{"key":"1921_CR106","doi-asserted-by":"publisher","unstructured":"Waddell N, Pajic M, Patch A-M, Chang DK, Kassahn KS, Bailey P, Johns AL, Miller D,Nones K, Quek K, Quinn MCJ, Robertson AJ, Fadlullah MZH, Bruxner TJC, Christ AN, Harliwong I, Idrisoglu S, Manning S, Nourse C, Nourbakhsh E, Wani S, Wilson PJ, Markham E, Cloonan N, Anderson MJ, Fink JL, Holmes O, Kazakoff SH, Leonard C, Newell F, Poudel B, Song S, Taylor D, Waddell N, Wood S, Xu Q, Wu J, Pinese M, Cowley MJ, Lee HC, Jones MD,Nagrial AM, Humphris J, Chantrill LA, Chin V, Steinmann AM, Mawson A, Humphrey ES,Colvin EK, Chou A, Scarlett CJ, Pinho AV, Giry-Laterriere M, Rooman I, Samra JS, Kench JG, Pettitt JA, Merrett ND, Toon C, Epari K, Nguyen NQ, Barbour A, Zeps N, Jamieson NB, Graham JS, Niclou SP, Bjerkvig R, Gr\u00fctzmann R, Aust D, Hruban RH, Maitra A, Iacobuzio-Donahue CA, Wolfgang CL, Morgan RA, Lawlor RT, Corbo V, Bassi C, Falconi M, Zamboni G, Tortora G, Tempero MA, Biankin AV, Johns AL, Mawson A, Chang DK, Scarlett CJ, Brancato M-AL,Rowe SJ, Simpson SH, Martyn-Smith M, Thomas MT, Chantrill LA, Chin VT, Chou A, Cowley MJ, Humphris JL, Jones MD, Scott Mead R, Nagrial AM, Pajic M, Pettit J, Pinese M,Rooman I, Wu J, Tao J, DiPietro R, Watson C, Steinmann A, Ching Lee H, Wong R, Pinho AV, Giry-Laterriere M, Daly RJ, Musgrove EA, Sutherland RL, Grimmond SM, Waddell N,Kassahn KS, Miller DK, Wilson PJ, Patch A-M, Song S, Harliwong I, Idrisoglu S, Nourse C, Nourbakhsh E, Manning S, Wani S, Gongora M, Anderson M, Holmes O, Leonard C, Taylor D, Wood S, Xu C, Nones K, Lynn Fink J, Christ A, Bruxner T, Cloonan N, Newell F, Pearson JV, Bailey P, Quinn M, Nagaraj S, Kazakoff S, Waddell N, Krisnan K, Quek K, Wood D,Fadlullah MZH, Samra JS, Gill AJ, Pavlakis N, Guminski A, Toon C, Asghari R, Merrett ND, Pavey D, Das A, Cosman PH, Ismail K, O\u2019Connnor C, Lam Duncan McLeod VW, Pleass HC, Richardson A, James V, Kench JG, Cooper CL, Joseph D, Sandroussi C, Crawford M,Gallagher J, Texler M, Forest C, Laycock A, Epari KP, Ballal M, Fletcher DR, Mukhedkar S, Spry NA, DeBoer B, Chai M, Zeps N, Beilin M, Feeney K, Nguyen NQ, Ruszkiewicz AR,Worthley C, Tan CP, Debrencini T, Chen J, Brooke-Smith ME, Papangelis V, Tang H, Barbour AP, Clouston AD, Martin P, O\u2019Rourke TJ, Chiang A, Fawcett JW, Slater K, Yeung S, Hatzifotis M, Hodgkinson P, Christophi C, Nikfarjam M, Mountain A, Eshleman JR, Hruban RH, Maitra A, Iacobuzio-Donahue CA, Schulick RD, Wolfgang CL, Morgan RA, Hodgin M, Scarpa A,Lawlor RT, Beghelli S, Corbo V, Scardoni M, Bassi C, Tempero MA, Biankin AV, Grimmond SM, Chang DK, Musgrove EA, Jones MD, Nourse C, Jamieson NB, Graham JS, Biankin AV,Chang DK, Jamieson NB, Graham JS, Oien K, Hair J, Gill AJ, Eshleman JR, Pilarsky C,Scarpa A, Musgrove EA, Pearson JV, Biankin AV, Grimmond SM, Australian Pancreatic Cancer Genome I, Garvan Institute of Medical R, Queensland Centre for Medical Genomics\/ Institute for Molecular B, Royal North Shore H, Bankstown H, Liverpool H, Westmead H, Royal Prince Alfred H, Fremantle H, Sir Charles Gairdner H, St John of God H, Royal Adelaide H, Flinders Medical C, Greenslopes Private H, Envoi P, Princess Alexandria H, Austin H, Victorian Cancer B, Johns Hopkins Medical I, Cancer AR-NCfARo, University of California SF, University of G, Greater G, Clyde National Health S (2015) Whole genomes redefine the mutational landscape of pancreatic cancer. Nature 518:495\u2013501. https:\/\/doi.org\/10.1038\/nature14169","DOI":"10.1038\/nature14169"},{"key":"1921_CR108","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1186\/s12885-019-6251-7","volume":"19","author":"Z Wang","year":"2019","unstructured":"Wang Z, Li Y, Zhan S, Zhang L, Zhang S, Tang Q, Li M, Tan Z, Liu S, Xing X (2019) SMAD4 Y353C promotes the progression of PDAC. BMC Cancer 19:1037. https:\/\/doi.org\/10.1186\/s12885-019-6251-7","journal-title":"BMC Cancer"},{"key":"1921_CR107","doi-asserted-by":"publisher","first-page":"3557","DOI":"10.1021\/acsnano.2c09948","volume":"17","author":"Y Wang","year":"2023","unstructured":"Wang Y, Tang Q, Wu R, Sun S, Zhang J, Chen J, Gong M, Chen C, Liang X (2023) Ultrasound-triggered piezocatalysis for selectively controlled NO gas and chemodrug release to enhance drug penetration in pancreatic cancer. ACS Nano 17:3557\u20133573. https:\/\/doi.org\/10.1021\/acsnano.2c09948","journal-title":"ACS Nano"},{"key":"1921_CR109","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1085\/jgp.8.6.519","volume":"8","author":"O Warburg","year":"1927","unstructured":"Warburg O, Wind F, Negelein E (1927) The metabolism of tumors in the body. J Gen Physiol 8:519\u2013530. https:\/\/doi.org\/10.1085\/jgp.8.6.519","journal-title":"J Gen Physiol"},{"key":"1921_CR110","doi-asserted-by":"publisher","first-page":"W214","DOI":"10.1093\/nar\/gkq537","volume":"38","author":"D Warde-Farley","year":"2010","unstructured":"Warde-Farley D, Donaldson SL, Comes O, Zuberi K, Badrawi R, Chao P, Franz M, Grouios C, Kazi F, Lopes CT, Maitland A, Mostafavi S, Montojo J, Shao Q, Wright G, Bader GD, Morris Q (2010a) The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res 38:W214\u2013W220. https:\/\/doi.org\/10.1093\/nar\/gkq537","journal-title":"Nucleic Acids Res"},{"key":"1921_CR111","doi-asserted-by":"publisher","first-page":"W214","DOI":"10.1093\/nar\/gkq537","volume":"38","author":"D Warde-Farley","year":"2010","unstructured":"Warde-Farley D, Donaldson SL, Comes O, Zuberi K, Badrawi R, Chao P, Franz M, Grouios C, Kazi F, Lopes CT, Maitland A, Mostafavi S, Montojo J, Shao Q, Wright G, Bader GD, Morris Q (2010b) The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res 38:W214\u2013220. https:\/\/doi.org\/10.1093\/nar\/gkq537","journal-title":"Nucleic Acids Res"},{"key":"1921_CR112","doi-asserted-by":"publisher","unstructured":"Waters AM, Der CJ (2018) KRAS: The critical driver and therapeutic target for pancreatic cancer. Cold Spring Harbor perspectives in medicine 8. https:\/\/doi.org\/10.1101\/cshperspect.a031435","DOI":"10.1101\/cshperspect.a031435"},{"key":"1921_CR113","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.cell.2014.01.066","volume":"157","author":"S Weissmueller","year":"2014","unstructured":"Weissmueller S, Manchado E, Saborowski M, Morris JPt, Wagenblast E, Davis CA, Moon SH, Pfister NT, Tschaharganeh DF, Kitzing T, Aust D, Markert EK, Wu J, Grimmond SM, Pilarsky C, Prives C, Biankin AV, Lowe SW (2014) Mutant p53 drives pancreatic cancer metastasis through cell-autonomous PDGF receptor beta signaling. Cell 157:382\u2013394. https:\/\/doi.org\/10.1016\/j.cell.2014.01.066","journal-title":"Cell"},{"key":"1921_CR114","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/nrgastro.2009.89","volume":"6","author":"HH Wong","year":"2009","unstructured":"Wong HH, Lemoine NR (2009) Pancreatic cancer: molecular pathogenesis and new therapeutic targets. Nat Rev Gastroenterol Hepatol 6:412\u2013422. https:\/\/doi.org\/10.1038\/nrgastro.2009.89","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1921_CR115","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.2147\/OTT.S232464","volume":"13","author":"C Wu","year":"2020","unstructured":"Wu C, Yang P, Liu B, Tang Y (2020) Is there a CDKN2A-centric network in pancreatic ductal adenocarcinoma? Onco Targets Ther 13:2551\u20132562. https:\/\/doi.org\/10.2147\/OTT.S232464","journal-title":"Onco Targets Ther"},{"key":"1921_CR116","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s12935-022-02640-9","volume":"22","author":"H Wu","year":"2022","unstructured":"Wu H, Ou S, Zhang H, Huang R, Yu S, Zhao M, Tai S (2022) Advances in biomarkers and techniques for pancreatic cancer diagnosis. Cancer Cell Int 22:220. https:\/\/doi.org\/10.1186\/s12935-022-02640-9","journal-title":"Cancer Cell Int"},{"key":"1921_CR117","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1158\/2159-8290.CD-23-1323","volume":"14","author":"N Yamaguchi","year":"2024","unstructured":"Yamaguchi N, Wu YG, Ravetch E, Takahashi M, Khan AG, Hayashi A, Mei W, Hsu D, Umeda S, de Stanchina E, Lorenz IC, Iacobuzio-Donahue CA, Tavazoie SF (2024) A Targetable Secreted Neural Protein Drives Pancreatic Cancer Metastatic Colonization and HIF1alpha Nuclear Retention. Cancer Discov 14:2489\u20132508. https:\/\/doi.org\/10.1158\/2159-8290.CD-23-1323","journal-title":"Cancer Discov"},{"key":"1921_CR118","doi-asserted-by":"publisher","unstructured":"Yang HH, Liu JW, Lee JH, Harn HJ, Chiou TW (2021) Pancreatic adenocarcinoma therapeutics targeting RTK and TGF beta receptor. Int J Mol Sci 22. https:\/\/doi.org\/10.3390\/ijms22158125","DOI":"10.3390\/ijms22158125"},{"key":"1921_CR119","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/nm.4333","volume":"23","author":"A Zehir","year":"2017","unstructured":"Zehir A, Benayed R, Shah RH, Syed A, Middha S, Kim HR, Srinivasan P, Gao J, Chakravarty D, Devlin SM, Hellmann MD, Barron DA, Schram AM, Hameed M, Dogan S, Ross DS, Hechtman JF, DeLair DF, Yao J, Mandelker DL, Cheng DT, Chandramohan R, Mohanty AS, Ptashkin RN, Jayakumaran G, Prasad M, Syed MH, Rema AB, Liu ZY, Nafa K, Borsu L, Sadowska J, Casanova J, Bacares R, Kiecka IJ, Razumova A, Son JB, Stewart L, Baldi T, Mullaney KA, Al-Ahmadie H, Vakiani E, Abeshouse AA, Penson AV, Jonsson P, Camacho N, Chang MT, Won HH, Gross BE, Kundra R, Heins ZJ, Chen HW, Phillips S, Zhang H, Wang J, Ochoa A, Wills J, Eubank M, Thomas SB, Gardos SM, Reales DN, Galle J, Durany R, Cambria R, Abida W, Cercek A, Feldman DR, Gounder MM, Hakimi AA, Harding JJ, Iyer G, Janjigian YY, Jordan EJ, Kelly CM, Lowery MA, Morris LGT, Omuro AM, Raj N, Razavi P, Shoushtari AN, Shukla N, Soumerai TE, Varghese AM, Yaeger R, Coleman J, Bochner B, Riely GJ, Saltz LB, Scher HI, Sabbatini PJ, Robson ME, Klimstra DS, Taylor BS, Baselga J, Schultz N, Hyman DM, Arcila ME, Solit DB, Ladanyi M, Berger MF (2017) Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients. Nat Med 23:703\u2013713. https:\/\/doi.org\/10.1038\/nm.4333","journal-title":"Nat Med"},{"key":"1921_CR120","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1097\/MPA.0000000000001136","volume":"47","author":"W Zhan","year":"2018","unstructured":"Zhan W, Shelton CA, Greer PJ, Brand RE, Whitcomb DC (2018) Germline variants and risk for pancreatic cancer: A systematic review and emerging concepts. Pancreas 47:924\u2013936. https:\/\/doi.org\/10.1097\/MPA.0000000000001136","journal-title":"Pancreas"},{"key":"1921_CR121","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/ng.3466","volume":"48","author":"X Zhou","year":"2016","unstructured":"Zhou X, Edmonson MN, Wilkinson MR, Patel A, Wu G, Liu Y, Li Y, Zhang Z, Rusch MC, Parker M, Becksfort J, Downing JR, Zhang J (2016) Exploring genomic alteration in pediatric cancer using ProteinPaint. Nat Genet 48:4\u20136. https:\/\/doi.org\/10.1038\/ng.3466","journal-title":"Nat Genet"},{"key":"1921_CR122","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s12943-021-01441-4","volume":"20","author":"G Zhu","year":"2021","unstructured":"Zhu G, Pei L, Xia H, Tang Q, Bi F (2021) Role of oncogenic KRAS in the prognosis, diagnosis and treatment of colorectal cancer. Mol Cancer 20:143. https:\/\/doi.org\/10.1186\/s12943-021-01441-4","journal-title":"Mol Cancer"}],"container-title":["Functional &amp; Integrative Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10142-026-01921-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10142-026-01921-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10142-026-01921-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:13:52Z","timestamp":1781223232000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10142-026-01921-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,12]]},"references-count":125,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["1921"],"URL":"https:\/\/doi.org\/10.1007\/s10142-026-01921-0","relation":{},"ISSN":["1438-793X","1438-7948"],"issn-type":[{"value":"1438-793X","type":"print"},{"value":"1438-7948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,12]]},"assertion":[{"value":"6 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"During the preparation of this work the author (s) used ChatGPT to find out grammatic errors. After using this tool, the author (s) reviewed and edited the content as needed and take (s) full responsibility for the content of the published article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Generative AI and AI-assisted technologies in the writing process"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Publish"}},{"value":"The authors declare no competing interests.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"135"}}